Center of Reproductive Medicine, Shengjing Hospital of China Medical University, Shenyang, 110004, China.
Department of Plastic Surgery, The First Affiliated Hospital of China Medical University, Shenyang, China.
Redox Biol. 2023 Jun;62:102659. doi: 10.1016/j.redox.2023.102659. Epub 2023 Mar 7.
Reactive oxygen species (ROS) are mainly produced in mitochondria and are involved in various physiological activities of the ovary through signaling and are critical for regulating the ovarian cycle. Notably, the imbalance between ROS generation and the antioxidant defense system contributes to the development of ovarian diseases. These contradictory effects have critical implications for potential antioxidant strategies that aim to scavenge excessive ROS. However, much remains to be learned about how ROS causes various ovarian diseases to the application of antioxidant therapy for ovarian diseases. Here, we review the mechanisms of ROS generation and maintenance of homeostasis in the ovary and its associated physiological effects. Additionally, we have highlighted the pathological mechanisms of ROS in ovarian diseases and potential antioxidant strategies for treatment.
活性氧(ROS)主要在线粒体中产生,并通过信号转导参与卵巢的各种生理活动,对调节卵巢周期至关重要。值得注意的是,ROS 产生与抗氧化防御系统之间的失衡导致了卵巢疾病的发展。这些矛盾的影响对于旨在清除过多 ROS 的潜在抗氧化策略具有重要意义。然而,ROS 如何导致各种卵巢疾病以及抗氧化治疗在卵巢疾病中的应用仍有许多需要了解的地方。在这里,我们综述了 ROS 在卵巢中产生和维持体内平衡及其相关生理效应的机制。此外,我们还强调了 ROS 在卵巢疾病中的病理机制和潜在的抗氧化治疗策略。